Position in GLAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,886,144
New position
Shares Held
1,145,088
first reported quarter
Ownership
1.22%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 53 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $2,155,261,599 across 33 Drug Manufacturers - Specialty & Generic names. GLAS ranks #9 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,379,025 | $747,197,111 | |
| 2 | ZTS |
Zoetis Inc.
|
9,423,895 | $677,201,094 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,671,157 | $259,898,795 | |
| 4 | ALKS |
Alkermes plc.
|
2,814,804 | $147,495,727 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
1,013,063 | $112,389,207 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
2,676,050 | $65,857,589 | |
| 7 | HLN |
Haleon plc
|
3,273,583 | $30,542,527 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,365,103 | $18,731,613 |
All Filings in GLAS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,886,144 | 1,145,088 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||